mg-k10
mAbexperimental
Clinical trial activity
5 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Jul 5, 2022 (NCT05382910)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06846385 | Phase 2/Phase 3 (Phase 3) | Mar 20, 2025 | Shanghai Mabgeek Biotech.Co.Ltd |
| NCT06765005 | Phase 1/Phase 2 (Phase 2) | Jul 19, 2024 | First People's Hospital of Hangzhou, Shanghai Mabgeek Biotech.Co.Ltd |
| NCT06277284 | N/A | Oct 23, 2023 | Anhui Medical University, Shanghai Mabgeek Biotech.Co.Ltd |
| NCT05466877 | Phase 2 | Aug 31, 2022 | Fudan University, Shanghai Mabgeek Biotech.Co.Ltd |
| NCT05382910 | Phase 1/Phase 2 (Phase 2) | Jul 5, 2022 | Guangzhou Medical University, Shanghai Mabgeek Biotech.Co.Ltd |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shanghai Mabgeek Biotech.Co.Ltd | Academic/Hospital | 5 | 5 | 3 | 2022 |
| Anhui Medical University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| First People's Hospital of Hangzhou | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Guangzhou Medical University | Academic/Hospital | 1 | 0 | 1 | 2022 |
5 organizations
Page 1 / 1